Effect of Luseogliflozin on Heart Failure With Preserved Ejection Fraction in Patients With Diabetes Mellitus
Association of Prior Left Ventricular Ejection Fraction With Clinical Outcomes in Patients With Heart Failure With Midrange Ejection Fraction
Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial
Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure
Cardiac Resynchronization Therapy and Ventricular Tachyarrhythmia Burden
Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure
Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"